Fractures: Clinical Trials

8 trials for Fractures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 7, Unknown 1

Follow Fractures: new trials by email Literature Review of Fractures trials Research Report on Fractures

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REDUCTION ACCURACY IN NASO-ORBITO-ETHMOIDAL FRACTURES AFTER VIRTUAL REDUCTION AND FIXATION USING PRE-ADAPTED MINIPLATES
pre-adapted titanium miniplates based on a virtually reduced 3D model - Naso-Orbito-Ethmoidal, Fractures
Phase 4CompletedAlexandria University152025-11-012026-10-21
The Effect of NSAID Use in the Acute Phase of Skeletally Immature Bone Healing: A Prospective Study
Acetaminophen, Ibuprofen - Fractures
Phase 4CompletedUniversity of Missouri-Columbia1022014-01-012019-03-05
The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures
Teriparatide, Placebo - Fractures
Phase 4UnknownOhio Orthopedic Center of Excellence382010-07-012012-06-05
Ketamine/Propofol vs Ketamine Alone for Pediatric Fracture Reduction
Ketamine only, Ketamine - Propofol - Fractures
Phase 4CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1402007-06-012017-08-25
Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures
Oxycodone hydrochloride - Fractures
Phase 4CompletedRambam Health Care Campus652007-04-012015-02-05
Antiepileptic Drugs and Osteoporotic Prevention Trial
Risedronate, Placebo + Calcium and Vitamin D - Epilepsy, Bone Loss
Phase 4CompletedBoston VA Research Institute, Inc.802006-06-012015-07-24
OSTPRE-Fracture Prevention Study
calcium carbonate and cholecalciferol - Fractures, Osteoporosis
Phase 4CompletedKuopio University Hospital34322002-08-012008-01-14
The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients
zoledronic acid - Osteoporosis, Liver Transplantation
Phase 4CompletedRoyal Prince Alfred Hospital, Sydney, Australia1002000-02-012006-05-09

Narrower conditions

Fractures, Bone (8)  ·  Osteoporosis (3)  ·  Bone Diseases, Metabolic (1)  ·  Emergencies (1)  ·  Epilepsy (1)  ·  Fractures, Closed (1)  ·  Fractures, Open (1)  ·  Seizures (1)  ·  Wounds and Injuries (1)

Broader conditions

Wounds and Injuries (7)  ·  Bone Diseases (3)  ·  Metabolic Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Bone Diseases, Metabolic (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Disease Attributes (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)

Interventions

Acetaminophen (1)  ·  Calcium (1)  ·  Calcium Carbonate (1)  ·  Cholecalciferol (1)  ·  Ibuprofen (1)  ·  Oxycodone (1)  ·  Risedronic Acid (1)  ·  Teriparatide (1)  ·  Vitamin D (1)  ·  Zoledronic Acid (1)

Sponsors

Alexandria University (1)  ·  Boston VA Research Institute, Inc. (1)  ·  Kuopio University Hospital (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Ohio Orthopedic Center of Excellence (1)  ·  Rambam Health Care Campus (1)  ·  Royal Prince Alfred Hospital, Sydney, Australia (1)  ·  University of Missouri-Columbia (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  Egypt (1)  ·  Finland (1)  ·  Israel (1)

Top investigators

Amit P Shah, MD FCFP(EM) (1)  ·  Antonio A Lazzari, MD (1)  ·  Daniel G Hoernschemeyer, MD (1)  ·  Geoffrey McCaughan, PhD, MB BS (1)  ·  Greg Mosdossy, MD, FRCPC (1)  ·  Heikki P Kroger, Professor (1)  ·  Manisha Thakore, MD (1)  ·  Marjo Tuppurainen, Professor (1)  ·  Michael J Rieder, MD PhD FRCPC (1)  ·  Peter H. Edwards, Jr., MD (1)  ·  Phillip Dussault, Pharm D (1)  ·  Ruth Edery, MD (1)

Results publications

PMID 16490909, PMID 20200964, PMID 20204604